| Previous Close | 45.34 |
| Open | 44.40 |
| Bid | 28.65 x 200 |
| Ask | 43.25 x 100 |
| Day's Range | 42.62 - 45.14 |
| 52 Week Range | 23.64 - 46.81 |
| Volume | 760,287 |
| Avg. Volume | 277,467 |
| Market Cap | 1.47B |
| Beta | 1.11 |
| PE Ratio (TTM) | 114.12 |
| EPS (TTM) | 0.38 |
| Earnings Date | Aug 2, 2017 - Aug 7, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.60 |
- GlobeNewswire•3 hours ago
Repligen Corporation Prices Public Offering of Shares of Common Stock
WALTHAM, Mass., June 27, 2017-- Repligen Corporation today announced the pricing of an underwritten public offering of 2,807,017 shares of its common stock at a public offering price of $42.75 per share. ...
- GlobeNewswire•yesterday
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
WALTHAM, Mass., June 26, 2017-- Repligen Corporation today announced that it has commenced an underwritten public offering of $100,000,000 in shares of its common stock. In addition, Repligen Corporation ...
- Accesswire•2 days ago
Corporate News Blog - Repligen Corp. and Spectrum Merge to Form Leader in Filtration for Bioprocessing Industry
Research Desk Line-up: BioPharmX Corporation Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 26, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ...